| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.094 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.092 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.47 | 0.1 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |